CLASS ACTION REMINDER: Berger Montague Advises Rocket Pharmaceuticals (RCKT) Investors to Inquire About a Securities Fraud Lawsuit by August 11, 2025
Rocket Pharmaceuticals, headquartered in Cranbury, New Jersey, is a biotechnology company focused on developing gene therapies for rare diseases.
The suit alleges that the Company failed to inform investors of a substantial protocol change, specifically the addition of a novel immunomodulatory agent, prior to a serious adverse event (SAE) and subsequent FDA clinical hold. Following the Company's disclosure of a patient death in the trial, RCKT shares fell nearly 37%, from $6.27 on May 23, 2025, to $2.33 on May 27, 2025.
Investor Deadline: Investors who purchased Rocket Pharmaceuticals securities between September 17, 2024 and May 26, 2025 (the 'Class Period') may be eligible to seek recovery. The deadline to apply for lead plaintiff is August 11, 2025. To learn your rights,CLICK HERE.
About Berger Montague
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco and Chicago, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
For more information or to discuss your rights, please contact:
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
Caitlin Adorni
Berger Montague
(267) 764-4865
[email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/260084
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Why NIKE (NKE) Could Be a Comeback Story Among the Dogs of the Dow
NIKE, Inc. (NYSE:NKE) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. A close-up of a hand holding a casual sneaker with the Nike logo on it. The world's biggest footwear company stated on Thursday that existing tariffs might push its costs up by around $1 billion. This announcement followed the release of its fiscal fourth-quarter 2025 results, which managed to surpass estimates. In fiscal Q4 2025, NIKE, Inc. (NYSE:NKE) reported revenue of $11.1 billion, which fell by nearly 12% from the same period last year. However, the revenue surpassed analysts' estimates by $373.5 million. The fourth quarter marked the period with the most significant financial impact from the company's 'Win Now' initiatives, and management expects these pressures to ease going forward. Leadership expressed confidence in the firm's ability to steer through the current unpredictable environment by maintaining focus on controllable factors and effectively carrying out the 'Win Now' strategy. NIKE, Inc. (NYSE:NKE)'s cash position also remained stable. The company ended the year with cash and equivalents and short-term investments of $9.2 billion. During the year, it returned $2.3 billion to shareholders through dividends. The company offers a quarterly dividend of $0.40 per share and has a dividend yield of 2.10%, as of July 26. It has raised its payouts for 23 consecutive years. While we acknowledge the potential of NKE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Dogs of the Dow: Why Procter & Gamble (PG) is a Pillar of Dividend Stability
The Procter & Gamble Company (NYSE:PG) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. A happy couple viewing the products of this household and personal product company in a mass merchandiser store. The Procter & Gamble Company (NYSE:PG) owns several leading consumer brands like Pampers and Tide— products that are considered essentials for many households. While there's always a possibility that consumers could opt for cheaper, generic alternatives, recent sales figures don't indicate any major shift in buying behavior that would pose a serious threat to the business. The Procter & Gamble Company (NYSE:PG) is considered one of the most reliable dividend stocks in the market. Its stability comes from a wide range of top-tier brands in areas like beauty, health, grooming, home care, and family care. Thanks to strong customer loyalty and an efficient global supply chain, the company regularly posts profit margins that outperform many competitors. The Procter & Gamble Company (NYSE:PG)'s long-standing financial strength is further proven by its impressive 69 consecutive years of dividend increases, which is one of the longest growth streaks among publicly traded companies. On July 8, the company declared a quarterly dividend of $1.0568 per share, in line with its previous dividend. With a dividend yield of 2.67% as of July 26, PG is among the best dogs of the Dow. While we acknowledge the potential of PG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
22 minutes ago
- Yahoo
Why The Home Depot (HD) Remains a Reliable Dividend Pick in the Dogs of the Dow
The Home Depot, Inc. (NYSE:HD) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. An insurance broker discussing policy options with a homeowner. The company is facing challenges expanding its business amid a tough economic climate marked by elevated interest rates and growing caution among consumers when it comes to major purchases. Still, several positive trends could work in the company's favor. Housing inventory in the US remains tight compared to demand, and the average home is aging. In addition, homeowners have access to trillions of dollars in home equity that could be used for remodeling and improvements. As economic conditions stabilize or improve, Home Depot is likely to benefit from stronger demand. In the first quarter of 2025, The Home Depot, Inc. (NYSE:HD) reported revenue of $39.86 billion, up 9.44% from the same period last year. Comparable sales declined by 0.3%, while US comparable sales saw a slight increase of 0.2%. The company noted that fluctuations in foreign exchange rates had a negative effect, reducing overall comparable sales by about 70 basis points. The Home Depot, Inc. (NYSE:HD) reported an operating cash flow of $4.3 billion and ended the quarter with $1.4 billion in cash and cash equivalents. The company is a reliable dividend payer with 16 consecutive years of dividend growth under its belt. Currently, it offers a quarterly dividend of $2.30 per share for a dividend yield of 2.45%, as of July 26. While we acknowledge the potential of HD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
